GVHD treatment with extracorporeal photopheresis in Brazil: a national survey

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey

Bibliographic Details
Main Authors:	Giancarlo Fatobene, Ana Cordeiro, Livia Mariano, Marcia Silva, Luis Bouzas, Nelson Hamerschlak, Maria Cristina Macedo, Alessandra Petta, Vaneuza Funke, Yana Novis, Mary E Flowers, Vanderson Rocha
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137922000013

Similar Items

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
by: Ines Bojanic, et al.
Published: (2023-02-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

Advances in extracorporeal photopheresis
by: Zhanrui CHENG, et al.
Published: (2022-07-01)

GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation — successfully treated by extracorporeal photopheresis
by: Kiavasch Mohammad Nejad Farid, et al.
Published: (2024-11-01)

Extracorporeal photopheresis in stiff person syndrome
by: Yandy Marx Castillo-Aleman, et al.
Published: (2024-12-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? : Beyond Current Dogma
by: Dalil eHannani
Published: (2015-07-01)

Extracorporeal photopheresis in chronic graft-versus-host disease: clinical description and economic study
by: Dora Fraga Vargas, et al.
Published: (2023-04-01)

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease
by: Adrian Peacock, et al.
Published: (2024-02-01)

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024-09-01)

The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review
by: Berhan A, et al.
Published: (2024-04-01)

Effect and mechanism of extracorporeal photopheresis on preventing acute graft versus host disease in ice
by: Zhanrui CHENG, et al.
Published: (2023-10-01)

A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis
by: David Bennett, et al.
Published: (2024-08-01)

In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells
by: Holger Budde, et al.
Published: (2017-05-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Sustained Complete Remission in Sézary Syndrome using Extracorporeal Photopheresis: A Multicentric Case Series
by: Rohat Cankaya, et al.
Published: (2024-11-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis
by: Valeria Behle, et al.
Published: (2017-05-01)

OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)

Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection
by: Arnaud Lionet, MD, et al.
Published: (2024-03-01)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024-03-01)

Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs
by: Sara Bozzini, et al.
Published: (2022-03-01)

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
by: Gabriel Afram, et al.
Published: (2019-04-01)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)

The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need
by: Jean-François Augusto, et al.
Published: (2024-05-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients
by: Yoshihiro Inamoto, et al.
Published: (2019-09-01)

Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis.
by: Whittle, R, et al.
Published: (2011)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model.
by: Holger Budde, et al.
Published: (2014-01-01)

Pneumocystis jirovecii Pneumonia during Brentuximab Vedotin Therapy: A Case Report and Literature Review
by: Aliana Meneses Ferreira, et al.
Published: (2019-01-01)